Loading…
Pliant Therapeutics, Inc. is projected to rise to $1.33 by 2027, a +7% move from its current price of $1.24. PLRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.22 | $1.24 | $1.26 | -0.02% |
| May 30 | $1.21 | $1.24 | $1.27 | -0.03% |
| May 31 | $1.20 | $1.24 | $1.28 | -0.05% |
| Jun 1 | $1.19 | $1.24 | $1.29 | -0.07% |
| Jun 2 | $1.19 | $1.24 | $1.29 | -0.08% |
| Jun 3 | $1.18 | $1.24 | $1.30 | -0.10% |
| Jun 4 | $1.18 | $1.24 | $1.30 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.18 | $1.24 | $1.30 | -0.11% |
| Week 2 | $1.15 | $1.24 | $1.33 | -0.23% |
| Week 3 | $1.13 | $1.24 | $1.35 | -0.34% |
| Week 4 | $1.12 | $1.23 | $1.36 | -0.45% |
| Week 5 | $1.10 | $1.23 | $1.38 | -0.57% |
| Week 6 | $1.09 | $1.23 | $1.39 | -0.68% |
| Week 7 | $1.08 | $1.23 | $1.40 | -0.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors.
It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Pliant Therapeutics, Inc. (PLRX) is a healthcare stock with current price $1.21. Its market position includes a market cap of $74.92M and a rank of 4405. The forecasted price path shows a gradual shift from near-term neutral to longer-term bullish potential.
In 2026 the average price is $1.21 (sentiment NEUTRAL), and by 2030 the average rises to $1.55 (ROI 28.3%, sentiment BULLISH). By 2050 the average is $5.82 (ROI 380.8%, sentiment BULLISH), illustrating meaningful upside potential over the long horizon.
A major floor 14.5% below — a decisive break under it would weaken the trend.
The nearest floor, 7.3% below — buyers have tended to step in here.
The nearest ceiling, 7.3% above — a clean break opens room to run.
A major ceiling 14.5% above — clearing it would confirm fresh momentum.
Key PLRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.22 | Buy | $1.22 | Buy |
| MA 10 | $1.19 | Buy | $1.21 | Buy |
| MA 20 | $1.20 | Buy | $1.21 | Buy |
| MA 50 | $1.25 | Sell | $1.24 | Buy |
| MA 100 | $1.26 | Sell | $1.29 | Sell |
| MA 200 | $1.39 | Sell | $1.80 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.58 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 109.68 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 1.64 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.25 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 63.20 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 1.25 | Sell |
| ADX (14) | 13.47 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is currently NEUTRAL. RSI14 is 50, which sits in the middle of typical momentum ranges. The 50-day simple moving average is $1.26 and the 200-day simple moving average is $1.40, indicating a price trend around its recent levels. Support is at $1.15 and resistance at $1.33, framing a modest near-term range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.09 | $1.24 | $1.51 | 0% | Neutral | |
| $1.09 | $1.33 | $1.71 | +7% | Neutral | |
| $1.07 | $1.33 | $1.75 | +7% | Neutral | |
| $1.14 | $1.44 | $1.93 | +16% | Neutral | |
| $1.28 | $1.64 | $2.24 | +32% | Bullish | |
| $1.44 | $1.86 | $2.59 | +50% | Bullish | |
| $1.63 | $2.14 | $3.01 | +73% | Bullish | |
| $1.61 | $2.13 | $3.04 | +72% | Bullish | |
| $1.58 | $2.12 | $3.06 | +71% | Bullish | |
| $1.76 | $2.38 | $3.47 | +92% | Bullish | |
| $2.46 | $3.46 | $5.28 | +179% | Bullish | |
| $4.20 | $6.35 | $10.38 | +412% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.09 | $1.24 | $1.45 | +0.00% |
| June 2026 | $1.06 | $1.24 | $1.47 | -0.06% |
| July 2026 | $1.04 | $1.22 | $1.47 | -1.41% |
| August 2026 | $1.05 | $1.24 | $1.50 | +1.27% |
| September 2026 | $1.05 | $1.24 | $1.50 | -0.03% |
| October 2026 | $1.01 | $1.20 | $1.47 | -3.04% |
| November 2026 | $1.00 | $1.19 | $1.46 | -0.64% |
| December 2026 | $1.02 | $1.22 | $1.51 | +2.43% |
Click any year to see its month-by-month PLRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PLRX could reach as high as $1.51, with a base case around $1.24 and support toward $1.09 — roughly 0% from $1.24. A consolidation phase looks the most probable path here.
Expect PLRX to range from $1.09 to $1.71 through 2027. The $1.33 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. Price action looks broadly range-bound.
The PLRX price prediction for 2028 points to an average of $1.33 (low $1.07, high $1.75) — a potential gain of +7% on today's $1.24. A consolidation phase looks the most probable path here.
In 2029, PLRX is projected to trade between $1.14 and $1.93, averaging $1.44 — a potential gain of +16% from today's $1.24. That is up +8% on the projected 2028 average. Price action looks broadly range-bound.
Pliant Therapeutics, Inc.'s 2030 outlook centres on $1.64, within a $1.28 to $2.24 range. That is up +14% on the projected 2029 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, PLRX could reach as high as $2.59, with a base case around $1.86 and support toward $1.44 — roughly +50% from $1.24. Momentum favours further upside here.
Expect PLRX to range from $1.63 to $3.01 through 2032. The $2.14 average target implies a +73% move from current prices. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The PLRX price prediction for 2033 points to an average of $2.13 (low $1.61, high $3.04) — a potential gain of +72% on today's $1.24. Momentum favours further upside here.
In 2034, PLRX is projected to trade between $1.58 and $3.06, averaging $2.12 — a potential gain of +71% from today's $1.24. That is -1% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Pliant Therapeutics, Inc.'s 2035 outlook centres on $2.38, within a $1.76 to $3.47 range. That is up +12% on the projected 2034 average. That marks a +92% change versus current levels. Momentum favours further upside here.
By 2040, PLRX could reach as high as $5.28, with a base case around $3.46 and support toward $2.46 — roughly +179% from $1.24. Buyers look set to stay in control over this stretch.
Expect PLRX to range from $4.20 to $10.38 through 2050. The $6.35 average target implies a +412% move from current prices. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PLRX today (≈ 806.451613 PLRX) could be worth
$5,117.99
+$4,117.99 (+412%) by 2050 · US Dollar
Based on the average projected PLRX price of $6.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLRXwould be worth at today's price.
$1,000 invested in PLRX on May 27, 2025 (≈ 781.250017 PLRX) would be worth
$968.75
-$31.25 (-3.1%) today · 0.97× · US Dollar
Based on a PLRX entry price of $1.28 vs. today's $1.24.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.2 | $1,033.33 | +3.3% |
| 1 month ago | $1.21 | $1,024.79 | +2.5% |
| 3 months ago | $1.29 | $961.24 | -3.9% |
| 6 months ago | $1.61 | $770.19 | -23.0% |
| 1 year ago | $1.28 | $968.75 | -3.1% |
| All time (5.0y) ago | $30.43 | $40.75 | -95.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLRX forecast.
Our base-case forecast reaches $2.50 around 2040.
Implied market cap at $2.50: $154.8M
The multi-year forecast shows a transition to BULLISH sentiment from 2030 onward, with progressively higher expected prices and ROIs. In 2030, the average price is $1.55 with an ROI of 28.3% and a BULLISH sentiment. The forecast extends to 2040 with an average of $3.22 and an ROI of 165.7%, and to 2050 with an average of $5.82 and an ROI of 380.8%.
The year-by-year path through 2029–2050 includes rising averages (e.g., 2031 $1.77, 2032 $2.02, 2033 $2.00, 2034 $2.00, 2035 $2.23) and culminates in substantial upside by mid-century. These figures are estimates and reflect projected upside with notable volatility; the forecast includes a 40% annualized volatility and should be considered with inherent uncertainty and risk.
Tap a question to reveal the answer.
Avg $1.55, min $1.21, max $2.13; ROI 28.3%; sentiment BULLISH.
The forecast shows an average price rising to $1.55 by 2030 and to $5.82 by 2050, with ROIs of 28.3% (2030) and 380.8% (2050). Current price is $1.21, with a market cap of $74.92M and rank 4405. Forecasts are estimates, not guarantees.
Yes—the forecast max price by 2050 is $9.57, with an average of $5.82. By 2040 the average is $3.22 and the max is $4.93, illustrating substantial upside potential by mid-century.
Current price is $1.21; market cap is $74.92M; rank is 4405.
Sentiment NEUTRAL; RSI14 is 50; SMA50 is $1.26; SMA200 is $1.40; support is $1.15; resistance is $1.33; the 30-day range is $1.07 to $1.37; annualized volatility is 40%.
Pliant Therapeutics, Inc. Community Discussion
0Share your Pliant Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.